Afficher la notice abrégée

dc.rights.licenseopenen_US
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorBELAROUSSI, Yaniss
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorROBLOT, Paul
dc.contributor.authorPEIFFER-SMADJA, N.
dc.contributor.authorDELAYE, T.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorMATHOULIN-PELISSIER, Simone
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorLEMEUX, Joffrey
dc.contributor.authorLE MOAL, G.
dc.contributor.authorCAUMES, E.
dc.contributor.authorROBLOT, F.
dc.contributor.authorBLEIBTREU, A.
dc.date.accessioned2021-03-03T15:50:06Z
dc.date.available2021-03-03T15:50:06Z
dc.date.issued2020-11-17
dc.identifier.issn2077-0383 (Print)en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/26411
dc.description.abstractEnBACKGROUND: During this pandemic situation, some studies have led to hasty conclusions about Corona Virus Disease-19 (COVID-19) treatment, due to a lack of methodology. This pedagogic study aimed to highlight potential biases in research on COVID-19 treatment. METHODS: We evaluate the effect of coffee's active part, 1,3,7-trimethylxanthine (TMX) on patients with COVID-19. A cohort of 93 patients, with a diagnosis of COVID-19 is analyzed. RESULTS: TMX group and control group included, respectively, 26 and 67 patients. In the TMX group, patients had a median length of stay in hospital of 5.5 days shorter than in the control group (9.5 vs. 15 days, p < 0.05). Patients in the control group were more severe than patients in the TMX group with a significantly higher National Early Warning Score 2 (NEWS-2 score) (8 vs. 6, p = 0.002). CONCLUSIONS: Multiple biases prevents us from concluding to an effect of coffee on COVID-19. Despite an important social pressure during this crisis, methodology and conscientiousness are the best way to avoid hasty conclusions that can be deleterious for patients. Identifier: NCT04395742.
dc.language.isoENen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.title.enWhy Methodology Is Important: Coffee as a Candidate Treatment for COVID-19?
dc.title.alternativeJ Clin Meden_US
dc.typeArticle de revueen_US
dc.identifier.doi10.3390/jcm9113691en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed33213035en_US
bordeaux.journalJournal of Clinical Medicineen_US
bordeaux.volume9en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - U1219en_US
bordeaux.issue11en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.teamEPICENE_BPH
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.exportfalse
bordeaux.COinSctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft.jtitle=Journal%20of%20Clinical%20Medicine&amp;rft.date=2020-11-17&amp;rft.volume=9&amp;rft.issue=11&amp;rft.eissn=2077-0383%20(Print)&amp;rft.issn=2077-0383%20(Print)&amp;rft.au=BELAROUSSI,%20Yaniss&amp;ROBLOT,%20Paul&amp;PEIFFER-SMADJA,%20N.&amp;DELAYE,%20T.&amp;MATHOULIN-PELISSIER,%20Simone&amp;rft.genre=article


Fichier(s) constituant ce document

Thumbnail
Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée